• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种用于骨髓活检中小血管密度测量的自动化图像分析工具。

Development of an Automated Image Analyzer for Microvessel Density Measurement in Bone Marrow Biopsies.

机构信息

Department of Laboratory Medicine, Kangdong Sacred Heart Hospital, Seoul, Korea.

Optical Research Team, Magok R&D Campus, Z-tec Co., Ltd., Seoul, Korea.

出版信息

Ann Lab Med. 2020 Jul;40(4):312-316. doi: 10.3343/alm.2020.40.4.312.

DOI:10.3343/alm.2020.40.4.312
PMID:32067430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7054689/
Abstract

Angiogenesis is important for the proliferation and survival of multiple myeloma (MM) cells. Bone marrow (BM) microvessel density (MVD) is a useful marker of angiogenesis and an increase in MVD can be used as a marker of poor prognosis in MM patients. We developed an automated image analyzer to assess MVD from images of BM biopsies stained with anti-CD34 antibodies using two color models. MVD was calculated by merging images from the red and hue channels after eliminating non-microvessels. The analyzer results were compared with those obtained by two experienced hematopathologists in a blinded manner using the 84 BM samples of MM patients. Manual assessment of the MVD by two hematopathologists yielded mean±SD values of 19.4±11.8 and 20.0±11.8. The analyzer generated a mean±SD of 19.5±11.2. The intraclass correlation coefficient (ICC) and Bland-Altman plot of the MVD results demonstrated very good agreement between the automated image analyzer and both hematopathologists (ICC=0.893 [0.840-0.929] and ICC=0.906 [0.859-0.938]). This automated analyzer can provide time- and labor-saving benefits with more objective results in hematology laboratories.

摘要

血管生成对于多发性骨髓瘤(MM)细胞的增殖和存活很重要。骨髓(BM)微血管密度(MVD)是血管生成的有用标志物,MVD 的增加可用作 MM 患者预后不良的标志物。我们开发了一种自动图像分析器,使用双色模型从抗 CD34 抗体染色的 BM 活检图像中评估 MVD。通过消除非微血管后,将红色和色调通道的图像合并以计算 MVD。使用 84 例 MM 患者的 BM 样本以盲法方式将分析仪结果与两位经验丰富的血液病理学家的结果进行比较。两位血液病理学家手动评估 MVD 的平均值±SD 值分别为 19.4±11.8 和 20.0±11.8。分析仪生成的平均值±SD 值为 19.5±11.2。MVD 结果的组内相关系数(ICC)和 Bland-Altman 图表明,自动图像分析仪与两位血液病理学家之间具有非常好的一致性(ICC=0.893 [0.840-0.929] 和 ICC=0.906 [0.859-0.938])。这种自动分析仪可以在血液学实验室提供节省时间和劳力的好处,并获得更客观的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9b2/7054689/5090e44faa79/alm-40-312-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9b2/7054689/8c12a0f9b838/alm-40-312-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9b2/7054689/5090e44faa79/alm-40-312-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9b2/7054689/8c12a0f9b838/alm-40-312-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9b2/7054689/5090e44faa79/alm-40-312-g002.jpg

相似文献

1
Development of an Automated Image Analyzer for Microvessel Density Measurement in Bone Marrow Biopsies.开发一种用于骨髓活检中小血管密度测量的自动化图像分析工具。
Ann Lab Med. 2020 Jul;40(4):312-316. doi: 10.3343/alm.2020.40.4.312.
2
Adverse prognostic impact of bone marrow microvessel density in multiple myeloma.骨髓微血管密度在多发性骨髓瘤中的不良预后影响。
Ann Lab Med. 2015 Nov;35(6):563-9. doi: 10.3343/alm.2015.35.6.563.
3
Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.骨髓血管生成在多发性骨髓瘤中的预后价值:利用光学显微镜以及计算机图像分析仪评估多发性骨髓瘤中的微血管密度和总血管面积及其与各种临床、组织学和实验室参数的相关性。
Am J Hematol. 2006 Sep;81(9):649-56. doi: 10.1002/ajh.20639.
4
Bone marrow angiogenesis in multiple myeloma and its correlation with clinicopathological factors.多发性骨髓瘤中的骨髓血管生成及其与临床病理因素的相关性。
Ann Hematol. 2010 Aug;89(8):789-94. doi: 10.1007/s00277-010-0919-z. Epub 2010 Feb 23.
5
Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.400例意义未明的单克隆丙种球蛋白病、多发性骨髓瘤和原发性淀粉样变性患者的骨髓血管生成
Clin Cancer Res. 2002 Jul;8(7):2210-6.
6
Assessment of bone marrow microvessel density in chronic lymphocytic leukemia.慢性淋巴细胞白血病中骨髓微血管密度的评估
Appl Immunohistochem Mol Morphol. 2010 Jul;18(4):353-6. doi: 10.1097/PAI.0b013e3181d18ae2.
7
Assessment of bone marrow fibrosis and angiogenesis in monitoring patients with multiple myeloma.评估骨髓纤维化和血管生成在监测多发性骨髓瘤患者中的作用。
Am J Clin Pathol. 2012 Jun;137(6):870-8. doi: 10.1309/AJCPT5Y2JRIUUCUB.
8
Microvessel Density as a Surrogate Prognostic Marker in Patients with Multiple Myeloma: A Meta-Analysis.微血管密度作为多发性骨髓瘤患者的替代预后标志物:一项荟萃分析
Acta Haematol. 2017;138(2):77-84. doi: 10.1159/000478085. Epub 2017 Aug 11.
9
Ki-67 Immunostaining and its Correlation with Microvessel Density in Patients with Mutiple Myeloma.多发性骨髓瘤患者的Ki-67免疫染色及其与微血管密度的相关性
Asian Pac J Cancer Prev. 2016;17(5):2559-64.
10
Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis.SSc 骨髓中血管生成减少的证据:免疫组织化学和多参数计算机成像分析。
Rheumatology (Oxford). 2012 Jun;51(6):1042-8. doi: 10.1093/rheumatology/ker447. Epub 2012 Jan 23.

引用本文的文献

1
Practical Aspects of Using Multifractal Formalism to Assess the Morphology of Biological Tissues.使用多重分形形式体系评估生物组织形态的实践方面
Sovrem Tekhnologii Med. 2023;15(3):35-40. doi: 10.17691/stm2023.15.3.04. Epub 2023 May 28.

本文引用的文献

1
Association of increased microvessel density with skeletal extramedullary disease relapse in multiple myeloma patients who have skeletal extramedullary disease at diagnosis.在诊断时患有骨骼髓外疾病的多发性骨髓瘤患者中,微血管密度增加与骨骼髓外疾病复发的关联。
Pathol Res Pract. 2018 Oct;214(10):1694-1699. doi: 10.1016/j.prp.2018.08.018. Epub 2018 Aug 19.
2
STK405759 as a combination therapy with bortezomib or dexamethasone, in and multiple myeloma models.STK405759与硼替佐米或地塞米松联合用于体内和体外多发性骨髓瘤模型的治疗。
Oncotarget. 2018 Jul 31;9(59):31367-31379. doi: 10.18632/oncotarget.25825.
3
Automated analysis of images for molecular quantification in immunohistochemistry.
免疫组织化学中用于分子定量的图像自动分析
Heliyon. 2018 Jun 29;4(6):e00669. doi: 10.1016/j.heliyon.2018.e00669. eCollection 2018 Jun.
4
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin protein MP0250: a preclinical study.通过VEGF和HGF阻断DARPin蛋白MP0250靶向多发性骨髓瘤中的血管生成:一项临床前研究。
Oncotarget. 2018 Jan 30;9(17):13366-13381. doi: 10.18632/oncotarget.24351. eCollection 2018 Mar 2.
5
Microvessel Density as a Surrogate Prognostic Marker in Patients with Multiple Myeloma: A Meta-Analysis.微血管密度作为多发性骨髓瘤患者的替代预后标志物:一项荟萃分析
Acta Haematol. 2017;138(2):77-84. doi: 10.1159/000478085. Epub 2017 Aug 11.
6
Crowdsourcing scoring of immunohistochemistry images: Evaluating Performance of the Crowd and an Automated Computational Method.众包免疫组化图像评分:评估人群和自动化计算方法的性能。
Sci Rep. 2017 Feb 23;7:43286. doi: 10.1038/srep43286.
7
Automated Ki-67 Quantification of Immunohistochemical Staining Image of Human Nasopharyngeal Carcinoma Xenografts.人鼻咽癌异种移植组织免疫组化染色图像的 Ki-67 全自动定量分析。
Sci Rep. 2016 Aug 26;6:32127. doi: 10.1038/srep32127.
8
Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.骨髓血管生成在多发性骨髓瘤中的预后价值:利用光学显微镜以及计算机图像分析仪评估多发性骨髓瘤中的微血管密度和总血管面积及其与各种临床、组织学和实验室参数的相关性。
Am J Hematol. 2006 Sep;81(9):649-56. doi: 10.1002/ajh.20639.
9
Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis.微血管密度作为乳腺癌女性患者的预后因素:文献系统综述与荟萃分析
Cancer Res. 2004 May 1;64(9):2941-55. doi: 10.1158/0008-5472.can-03-1957.
10
Tumorigenesis and the angiogenic switch.肿瘤发生与血管生成开关
Nat Rev Cancer. 2003 Jun;3(6):401-10. doi: 10.1038/nrc1093.